Skip to main content

HydroPeptide Names Dr. Lauren Jamieson as Company’s First Medical Director

A globally recognized expert in regenerative aesthetics, Dr. Jamieson will help shape the future of peptide-powered skincare in clinical practice.

HydroPeptide, a leader in clinically advanced, peptide-powered skincare, proudly announces the appointment of Dr. Lauren Jamieson, MBChB, MRCGP, as its new medical director. A respected voice in regenerative skin health, Dr. Jamieson brings over 15 years of clinical expertise and a results-driven, patient-led philosophy to the brand’s global leadership team.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250708726358/en/

HydroPeptide Names Dr. Lauren Jamieson as Company’s First Medical Director

HydroPeptide Names Dr. Lauren Jamieson as Company’s First Medical Director

As medical director, Dr. Jamieson will collaborate with HydroPeptide’s R&D, education, and clinical teams to further evolve the brand’s skin-first strategy. Her expertise will support the development of advanced protocols that integrate peptide technology with regenerative skincare, helping bridge the gap between professional treatments and long-term at-home results.

Dr. Jamieson is the founder and clinical director of Dr. Lauren Medical Aesthetics, a premier clinic known for its clinical ethos and precision-driven approach. Her practice blends advanced injectables with tailored skincare regimens that respect the aging process while helping restore radiance and balance.

“HydroPeptide has always been on the cutting edge of high-performing, science-led skincare, and their commitment to innovation and skin health mirrors my own clinical values,” said Dr. Jamieson. “I’m honored to have the opportunity to help shape the future of this exciting brand and expand its peptide-powered product line that beautifully combines transformative results with a luxurious user experience.”

“Dr. Jamieson embodies the ethos of HydroPeptide: intelligent, ethical, and grounded in real results, while sharing our commitment to innovative, clinically effective skincare that prioritizes long-term skin vitality over quick fixes,” said Annette Rubin, CEO of HydroPeptide. “Her support and extensive clinical expertise will be instrumental as we continue to deliver high-performance formulas designed to work in synergy with the skin.”

In addition to being the founder and clinical director of Dr. Lauren Medical Aesthetics, Dr. Jamieson is a member of the Primary Care Dermatology Society, with a special interest in cosmetic dermatology and evidence-based rejuvenation strategies. A graduate of the University of Glasgow, she began her medical career in surgical and anesthetic specialties before progressing into general practice, where she developed an interest in skin health and facial rejuvenation.

About HydroPeptide

Since 2004, HydroPeptide has been a leader in regenerative skincare, delivering transformative results through innovative peptide science and advanced delivery technologies. With more than 65 proprietary peptide complexes, HydroPeptide leads the way in clinically clean formulations that improve skin health at the cellular level. Backed by rigorous clinical and consumer testing, HydroPeptide products are trusted by professionals worldwide for their safety, efficacy, and proven performance—all of which meet the highest global standards.

For more information, visit https://hydropeptide.com/ and @HydroPeptide on social media. For media inquiries, please email hydropeptide@devriesglobal.com.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.